Quadriga Partners Research
Advisory Approach
Quadriga Partners is a dedicated healthcare investment bank founded in 2009 on the principle that traditional investment banking approaches do not necessarily serve healthcare companies best. The firm's philosophy is rooted in the metaphor of a quadriga—four horses harnessed together pulling a chariot—symbolizing how multiple perspectives and diverse expertise combined create exponential strength. Rather than pursuing transactional relationships, Quadriga treats clients as partners and focuses on building long-term relationships grounded in understanding each client's unique motivations and financial aspirations. This partnership-oriented approach means every deal is approached with a fresh analytical perspective, ensuring that client goals are not restricted by one-size-fits-all structures.
The firm's thesis is that healthcare companies deserve advisory partners who combine deep industry knowledge with genuine commitment to client outcomes. By maintaining an exclusive focus on healthcare, Quadriga has developed unparalleled expertise in the nuances, regulatory requirements, and dynamics of healthcare M&A that generalist banks cannot match. This specialization translates to more sophisticated execution, better navigation of healthcare-specific complexities, and stronger relationships with healthcare buyers and financial sponsors.
Sector Focus and Vertical Expertise
Quadriga operates across multiple healthcare verticals with particular depth in physician practice management, clinical research, healthcare services, and medical services. Their team has completed transactions across orthopedic practices, ophthalmology practices, physical therapy networks, hospice services, clinical research sites, and healthcare staffing operations. Within each vertical, the firm combines sector-specific expertise with operational experience.
In physician practice management, Quadriga has advised leading practices including Panorama Orthopedics & Spine Center (a 40+ surgeon orthopedic group performing 15,000 surgeries annually), OrthoNebraska (25+ specialty-trained orthopedic physicians), and multiple ophthalmology practices. The firm understands the unique challenges of consolidation in specialist-led practices: managing physician partner alignment, structuring equity rollover provisions, navigating regulatory compliance, and positioning practices for growth.
In clinical research and outsourced pharma services, Quadriga has advised on transactions involving clinical research sites, Phase I-IV trial operators, and specialized research facilities. The firm recognizes the sector's consolidation drivers: demand for quality and speed in drug development, geographic expansion requirements, therapeutic area diversification, and the institutional capital seeking healthcare services platforms.
Deal Track Record
Quadriga has completed approximately 12 transactions (7 M&A and 5 funding rounds) as of January 2026, all exclusively in healthcare. Recent transactions include:
Flourish Research Acquisition of CARE (May 2025): Quadriga advised the Center for Advanced Research & Education, a multi-therapeutic clinical research facility in Gainesville, GA founded in 1998 that had conducted 150+ clinical trials. This transaction expanded Flourish's geographic footprint and enhanced their oncology capabilities. This deal demonstrates Quadriga's expertise in clinical research and the growing consolidation in this subsector.
OrthoNebraska Partnership with InTandem Capital Partners (August 2023): Quadriga advised the leading Omaha-based orthopedic practice (25+ specialty physicians, integrated hospital and PT clinics) on its partnership with InTandem Capital Partners, creating a preeminent musculoskeletal platform. Jason Ficken, Quadriga's Managing Partner, commented on the ideal nature of this client and transaction, highlighting the firm's ability to lead sophisticated processes for established practices.
Carolina Cataract & Laser Center and Eyecare Physicians & Surgeons Partnerships with EyeSouth Partners (August 2023): Quadriga advised two leading South Carolina ophthalmology practices on partnerships with EyeSouth Partners, expanding EyeSouth's presence to 12 states. This transaction represented EyeSouth's first two South Carolina affiliations, demonstrating Quadriga's ability to facilitate strategic consolidation in specialty healthcare.
Exos Divestiture of Physical Therapy MSA Division to IncreMedical (January 2023): Quadriga advised on the sale of Exos's physical therapy managed services agreement business (8-state footprint) to IncreMedical/Confluent Health (Partners Group portfolio company), expanding IncreMedical's reach from 41 locations to 12+ additional states. This demonstrates Quadriga's expertise in healthcare services divestitures and network expansion transactions.
Keystone Clinical Studies Recapitalization with Flourish Research (November 2022): Quadriga advised Keystone Clinical Studies, a specialized Alzheimer's disease and CNS clinical research site founded in 2003, on its recapitalization by Flourish Research/NMS Capital. Keystone had established a leading reputation in the Philadelphia market and nationally for excellence in CNS research. Dr. Verghese, founder and CEO, specifically praised Quadriga's thorough process, rapid exploration of partnership options, and successful matching with an ideal partner.
Panorama Orthopedics & Spine Center Recapitalization with U.S. Bancorp (October 2018): Quadriga advised Panorama, a 70+ year-old vertically integrated orthopedic system in Denver (40+ surgeons, 15,000 surgeries annually, specialty hospital), on a debt capital raise with U.S. Bancorp. This transaction provided meaningful shareholder liquidity while maintaining full physician control of the organization's future.
Competitive Positioning
Quadriga differentiates from larger healthcare banks through several mechanisms:
Sector Focus: Unlike national banks that cover healthcare across dozens of markets and geographies, Quadriga is exclusively focused on healthcare. Every banker on the team works only in healthcare, allowing deep sector expertise and relationship networks that generalist banks cannot maintain.
Partnership Philosophy: The firm's commitment to long-term partnerships rather than individual transactions means repeated work with sophisticated clients. This drives referral work and deep repeat relationships with buyers and sponsors active in healthcare.
Operational Expertise: Team members include professionals with operational backgrounds in healthcare, not just banking backgrounds. This allows them to understand not just the financial structure of deals but the operational implications and integration challenges.
Process Quality: Client testimonials consistently highlight the thoroughness and sophistication of Quadriga's process. OrthoNebraska praised the "meticulous organization and attention to detail." Keystone highlighted Quadriga's "thorough process" and ability to "move very quickly."
Buyer Network and Capital Relationships
Quadriga has deep relationships with PE firms and strategic buyers active in healthcare consolidation. Recent deals demonstrate relationships with InTandem Capital Partners, EyeSouth Partners, Flourish Research/NMS Capital, Partners Group, and institutional lenders like U.S. Bancorp. The firm's consistent flow of deal activity demonstrates ongoing, strong relationships with healthcare PE sponsors, strategic acquirers, and lenders.
Team and Organization
Quadriga's leadership includes Jason Ficken (Managing Partner, described as deeply committed to thorough client processes), Shane Guenther (Managing Director), Mrigasha Patel (Managing Director), and a team of approximately 10-12 bankers and analysts. The firm maintains operations from their Denver headquarters at 44 Cook Street.
Fee Structure and Engagement Model
Quadriga employs flexible engagement structures adapted to client circumstances. Transactions have ranged from sell-side M&A advisory to recapitalization financings to strategic advisory services. The firm's focus on partnership relationships suggests willingness to align fees with outcomes and work collaboratively with clients on deal structures.
Geographic Coverage and Market Position
Quadriga is headquartered in Denver, Colorado, but operates nationally with clients throughout the United States. Recent transaction activity demonstrates active engagement across the Southeast (South Carolina, Georgia), Midwest (Nebraska, Ohio), Southwest (Colorado), and broader U.S. markets.
Market Opportunity and Outlook
The healthcare M&A market remains robust. Clinical research consolidation is accelerating due to pharma demand for speed and quality. Physician practice consolidation continues as independent practices seek operational support and capital access. Quadriga's exclusive focus on healthcare and deep relationships position the firm to participate in ongoing healthcare sector consolidation.